Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansgar Heck

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
European Journal of Endocrinology|February 24, 2024
Long-term depot specific changes in adipose tissue after treatment of acromegalyCamilla M Falch, Kristin Godang, Tove Lekva, et al.
JBMR Plus|October 9, 2023
Endocortical Trabecularization in Acromegaly: The Cause for the Paradoxically Increased Vertebral Fracture Risk?Ansgar Heck, Kristin Godang, Tove Lekva, et al.
Clinical Endocrinology|November 10, 2011
Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegalyAnsgar Heck, Geir Ringstad, Stine L Fougner, et al.
Pituitary|April 11, 2025
Pasireotide as first line medical therapy for selected patients with acromegalyNicoleta C Olarescu, Anders P Jørgensen, Shahriar Atai, et al.
Plos One|July 5, 2013
Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recoveryTove Lekva, Jens Petter Berg, Ansgar Heck, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|April 25, 2024
Unravelling pituitary tumours in medically treated patients with acromegaly: the impact of systematic MRI reassessmentShahriar Atai, Martin Knudtzon Andersen, Markus Wiedmann, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2013
Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotideOlivera Casar-Borota, Ansgar Heck, Stefan Schulz, et al.
Acta Neurochirurgica|September 4, 2023
Long-term control of acromegaly after pituitary surgery in South-Eastern NorwayCamilla M Falch, Anne K Dupont, Nicoleta C Olarescu, et al.
Endocrine Connections|October 10, 2018
The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidismKristin Godang, Karolina Lundstam, Charlotte Mollerup, et al.
JBMR Plus|December 18, 2019
Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort StudyKristin Godang, Tove Lekva, Kjersti Ringvoll Normann, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Endocrinology|February 24, 2024
Long-term depot specific changes in adipose tissue after treatment of acromegalyCamilla M Falch, Kristin Godang, Tove Lekva, et al.
JBMR Plus|October 9, 2023
Endocortical Trabecularization in Acromegaly: The Cause for the Paradoxically Increased Vertebral Fracture Risk?Ansgar Heck, Kristin Godang, Tove Lekva, et al.
Clinical Endocrinology|November 10, 2011
Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegalyAnsgar Heck, Geir Ringstad, Stine L Fougner, et al.
Pituitary|April 11, 2025
Pasireotide as first line medical therapy for selected patients with acromegalyNicoleta C Olarescu, Anders P Jørgensen, Shahriar Atai, et al.
Plos One|July 5, 2013
Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recoveryTove Lekva, Jens Petter Berg, Ansgar Heck, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|April 25, 2024
Unravelling pituitary tumours in medically treated patients with acromegaly: the impact of systematic MRI reassessmentShahriar Atai, Martin Knudtzon Andersen, Markus Wiedmann, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2013
Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotideOlivera Casar-Borota, Ansgar Heck, Stefan Schulz, et al.
Acta Neurochirurgica|September 4, 2023
Long-term control of acromegaly after pituitary surgery in South-Eastern NorwayCamilla M Falch, Anne K Dupont, Nicoleta C Olarescu, et al.
Endocrine Connections|October 10, 2018
The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidismKristin Godang, Karolina Lundstam, Charlotte Mollerup, et al.
JBMR Plus|December 18, 2019
Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort StudyKristin Godang, Tove Lekva, Kjersti Ringvoll Normann, et al.
Pageof 5